Vaxxas has appointed former Merck Global Vaccines president David Peacock as chief executive officer (CEO), marking a step in ...

Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its MAP platform. We believe rethinking how treatments are ...

Marine microbial communities are complex, composed of diverse groups of Bacteria, Archaea, Eukaryotes and viruses. Molecular techniques frequently used in marine microbial ecology have shown ...

Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.

Figure 1: A schematic diagram that illustrates the steps involved in content generation, processing and data analysis for antigen microarrays. Antigen-specific tolerization with epitopes of oral type ...

Thanks to this tiny piece of tech, people with profound vision loss can now read, do cross word puzzles, and navigate public ...

Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...

Brisbane-based biotech company Vaxxas has appointed veteran pharmaceutical industry leader David Peacock as its new CEO as it moves to commercialise its needly free vaccination technology. Mr Peacock ...

Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...

One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...